Vertebral sarcoidosis mimicking lytic osseous metastases: Development 16 years after apparent resolution of thoracic sarcoidosis

Journal of Clinical Rheumatology

Volumn 11, Issue 2, 2005, Pages 105-108

  Packer, Clifford D ^a,b,d   Mileti, Linda M ^c  

^a Louis Stokes Cleveland Vet A M C ^*  (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Bone metastases; Vertebral sarcoidosis

Indexed keywords

PREDNISONE;

ACID FAST BACTERIUM; ADULT; ARTICLE; BIOPSY; BONE METASTASIS; BONE SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; GRANULOMATOUS INFLAMMATION; HUMAN; LYMPH NODE BIOPSY; MALE; MULTIPLE ORGAN FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RARE DISEASE; SARCOIDOSIS; VERTEBRA BODY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; RECURRENCE; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; SPINAL DISEASES; SPINAL NEOPLASMS; THORACIC VERTEBRAE; TIME FACTORS;

EID: 17744381967     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000158538.29753.b8     Document Type: Article

References (28)

1. Rua-Figueroa I, Gantes MA, Erausquin C, et al. Vertebral sarcoidosis: clinical and imaging findings. Semin Arthritis Rheum. 2002;31:346-352.
2. Rodman T, Funderburk EE Jr, Myerson RM. Sarcoidosis with vertebral involvement. Ann Intern Med. 1959;50:213-218.
3. Malterre L, Schenk S, Van Linthoudt D. Vertebral sarcoidosis of late discovery. Schweiz Rundsch Med Prax 2002;91:1266-1268.
4. James DG, Neville E, Carstairs LS. Bone and joint sarcoidosis. Semin Arthritis Rheum. 1976;6:53-81.
5. Perlman SG, Damergis J, Witorsch P, et al. Vertebral sarcoidosis with paravertebral ossification. Arthritis Rheum. 1978;21:271-277.
6. Cohen NP, Gosset J, Staron RB, et al. Vertebral sarcoidosis of the spine in a football player. Am J Orthop. 2001;30:875-877.
7. Tzagarakis GP, Papagelopoulos PJ, Sapkas GS, et al. Surgical management for instability and paraplegia caused by spinal sarcoidosis. A case report. Spine. 1998;23:1711-1714.
8. Engle EA, Cooney FD. Tetraplegia secondary to cervical sarcoidosis. Case report. J Neurosurg. 1979;50:665-667.
9. Resnick CS, Young JWR, Aisner SC, et al. Case report 594: osseous sarcoidosis (osteolytic) of lumbar spine and pelvis. Skeletal Radiol. 1990;19:79-81.
10. Shaikh S, Soubani A, Rumore P, et al. Lytic osseous destruction in vertebral sarcoidosis. N Y St J Med. 1992;92:213-214.
11. Ginsberg LE, Williams DW III, Stanton C. MRI of vertebral sarcoidosis. J Comput Assist Tomogr. 1992;17:158-159.
12. Alavi A, Buchpiguel CA, Loessner A. Is there a role for FDG PET imaging in the management of patients with sarcoidosis? J Nucl Med. 1994;35:1650-1652.
13. Ludwig V, Fordice S, Lamar R, et al. Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy. Clin Nucl Med. 2003;28:176-179.
14. Aberg C, Fabio P, Raphael B, et al. FDG positron emission tomography of bone involvement in sarcoidosis. AJR Am J Roentgenol. 2004;182: 975-977.
15. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology. 2001;219:774.
16. Kole A, Nieweg O, Hoekstra H, et al. Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med. 1998; 39:810.
17. Kobayashi A, Shinozaki T, Shinjyo Y, et al. FDG PET in the evaluation of sarcoidosis with bone lesion. Ann Nucl Med. 2000;14:311.
18. Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47.
19. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis Study: effects of long-term corticosteroid treatment. Thorax. 1996;51:238-247.
20. Wilcox A, Bharadwaj P, Sharma OP. Bone sarcoidosis. Curr Opin Rheumatol. 2000;12:321-330.
21. Kaye O, Palazzo E, Grossin M, et al. Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol. 1995;34:642-644.
22. Mana J, Gomez-Vaquero C, Dorca J, et al. Vertebral and rib sarcoidosis: long-term clinical remission with methotrexate. Clin Rheumatol. 1999; 18:492-444.
23. Silver HM, Shickhoda A, Simon DB. Symptomatic osseous sarcoidosis with findings on bone scan. Chest. 1978;73:238-241.
24. Franco M, Passeron C, Tieulie N, et al. Long term radiographic follow-up in a patient with osteosclerotic sarcoidosis of the spine and pelvis. Rev Rheum (Engl Ed). 1998;65:586-590.
25. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med. 1983;52: 525-533.
26. Zych D, Krychniak W, Pawlicka L, et al. Sarcoidosis of the lung: natural history and effects of treatment. Sarcoidosis. 1987;4:64-67.
27. Tazi A, Desmazes-Dufeu N, Bozzolo B, et al. Late recurrences of spontaneously resolved mediastinal-pulmonary sarcoidosis. Rev Mal Respir. 1994;11:285-288.
28. Mana J, Montero A, Vidal M, et al. Recurrent sarcoidosis: a study of 17 patients with 24 episodes of recurrence. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:212-221.